Suppr超能文献

血管内腹主动脉瘤修复术——患者选择与长期预后期望——2013年的当前挑战

Endovascular Abdominal Aortic Aneurysm Repair - Patient Selection and Long-term Outcome Expectations - Current Challenges in 2013.

作者信息

von Allmen Regula S, Dick Florian, Wyss Thomas R, Greenhalgh Roger M

机构信息

Imperial College Vascular Surgery Research Group, Division of Surgery, Oncology, ReproductiveBiology and Anaesthetics, Charing Cross Hospital, London, UK.

出版信息

Interv Cardiol. 2013 Mar;8(1):57-60. doi: 10.15420/icr.2013.8.1.57.

Abstract

Endografts for repair of abdominal aortic aneurysm were first reported in the late 1980s and commercially available grafts were developed rapidly during the 1990s. This prompted a head-to-head comparison of the new, less invasive, endovascular technology with the existing gold standard of open repair. The first and largest randomised trial of open versus endovascular repair for large aneurysms started in the UK in 1999. Other trials comparing open and endovascular repair followed in the Netherlands, France and the US. Only the UK trial has reported long-term follow-up to 10 years. This has shown no statistically significant difference in long-term survival after open or endovascular repair. Aneurysm-related mortality curves converged at six years, which is described as endovascular aortic repair (EVAR) 'catch up' on open repair. It appears that this convergence is probably largely attributable to secondary sac rupture after endovascular repair, which is fatal in about two-thirds of cases. At this point, we have reached a crossroads and only longer-term follow-up data can provide the vital answer to the outcome of endovascular repair in the long run. This article gives a brief overview of the development and the current evidence of endovascular aortic repair and discusses the most important factors that are leading the way to the future of this technology.

摘要

用于修复腹主动脉瘤的腔内移植物最早于20世纪80年代末被报道,20世纪90年代商用移植物迅速发展。这促使人们将这种新的、侵入性较小的血管内技术与现有的开放修复金标准进行直接比较。1999年,英国开展了第一项也是最大规模的关于大型动脉瘤开放修复与血管内修复的随机试验。随后,荷兰、法国和美国也进行了其他比较开放修复和血管内修复的试验。只有英国的试验报告了长达10年的长期随访结果。结果显示,开放修复或血管内修复后的长期生存率没有统计学上的显著差异。动脉瘤相关死亡率曲线在6年后趋于一致,这被描述为血管内主动脉修复(EVAR)在开放修复方面的“追赶”。看来这种趋同可能主要归因于血管内修复后瘤腔继发破裂,约三分之二的病例会因此致命。至此,我们已到了一个十字路口,只有长期随访数据才能从长远角度为血管内修复的结果提供至关重要的答案。本文简要概述了血管内主动脉修复的发展及当前证据,并讨论了引领该技术未来发展的最重要因素。

相似文献

本文引用的文献

1
Predictors of abdominal aortic aneurysm sac enlargement after endovascular repair.腹主动脉瘤血管内修复术后瘤囊增大的预测因素。
Circulation. 2011 Jun 21;123(24):2848-55. doi: 10.1161/CIRCULATIONAHA.110.014902. Epub 2011 Apr 10.
5
Endovascular versus open repair of abdominal aortic aneurysm.血管内与开放修复腹主动脉瘤。
N Engl J Med. 2010 May 20;362(20):1863-71. doi: 10.1056/NEJMoa0909305. Epub 2010 Apr 11.
10
The UK Endovascular Aneurysm Repair (EVAR) trials: design, methodology and progress.
Eur J Vasc Endovasc Surg. 2004 Apr;27(4):372-81. doi: 10.1016/j.ejvs.2003.12.019.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验